The pharmaceutical importance of viruses
Start with the big picture
Pharmaceutical applications of viruses span therapeutic delivery, vaccine production, and research tools. Engineered adenovirus, AAV, and lentivirus vectors deliver therapeutic genes, while oncolytic viruses can replicate in tumors and help trigger antitumor immunity. Bacteriophages are being considered against multidrug-resistant bacteria and can carry gene-editing tools. Viral enzymes support molecular biology and vaccine manufacturing; virus-like particles offer non-infectious vaccine scaffolds. Other applications include antiviral target development, resistance surveillance, monoclonal antibodies, and recombinant production of biopharmaceuticals. These uses depend on understanding how each platform works and balancing its potential with safety, biosafety, and manufacturing requirements. The full lesson connects these applications to their mechanisms and pharmaceutical context.
What you'll learn
- Describe how viral vectors deliver therapeutic genetic material.
- Explain the therapeutic rationale for oncolytic viruses and bacteriophages.
- Identify uses of viral enzymes and virus-like particles in biotechnology and vaccines.
- Summarize how viral targets and resistance surveillance inform antiviral development.
- Recognize pharmaceutical uses of monoclonal antibodies and recombinant viruses.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
